| Ticker: | SGMT |
| Current Price: | $9.58 |
| % Daily Change: | -3.72% |
| Volume (1,000s): | 694.95 |
| Average Volume (1,000s): | 0.00 |
| Market Cap (M): | $312.13 |
| 1/2/2024 Price: | $6.01 |
| Change Since Inception: | 59.40% |
Sagimet Biosciences Inc.
155 Bovet Road
Suite 303
San Mateo, CA 94402
United States
Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors.